tirzepatide south africa FDA Grants a New Indication for Obesity Management Weight Management & Slimming -

Next Steps: Personalizing Your Routine Every body is different, and your liver's needs might be different from your neighbor's

If it has to grow into this valuation with an exit P/E of 25x by 2030, it should grow its EPS by 20% CAGR

7.4.4 Next-generation agonists The development of dual GLP-1/GIP receptor agonists (e.g., tirzepatide) and novel blood-brain barrier-penetrant formulations may offer superior neuroprotective efficacy by more potently engaging central receptors or providing a broader spectrum of action (Ghaleb et al., 2025)

Duration of Effect Oral supplements maintain steady-state levels when taken daily